“…The underlying diseases or clinical conditions that led to the indication of ECMO were cystic fibrosis, (11,19,20,23,31-33,36) pulmonary fibrosis, (11,19,20,23,31-33,36) acute respiratory failure, (21,24,25,36) acute respiratory distress syndrome (ARDS), (11,29,33,35) chronic obstructive pulmonary disease, (11) idiopathic pulmonary disease, (11) pulmonary arterial hypertension, (11) usual interstitial pneumonia, (19) acute viral interstitial pneumonia, (28) pneumonia, (19) bridge to lung transplantation (LT), (22,26,34) asthma, (27) lymphangioleiomyomatosis, (23) pleuroparenchymal fibroelastosis, (32) pulmonary embolism, (37) cardiogenic shock, (37) and ventricular dysfunction after cardiac procedure. (37) One study (30) did not report the reason for using ECMO in the sample (n = 10).…”